Pablo Altman Selected Research

Bronchodilator Agents (Bronchodilators)

1/2017	LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
8/2015	Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.
9/2014	Addressing unmet needs in the treatment of COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Altman Research Topics

Disease

13	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 04/2014
6	Asthma (Bronchial Asthma) 02/2023 - 09/2018
4	Inflammation (Inflammations) 12/2023 - 09/2018
2	Dyspnea (Shortness of Breath) 01/2017 - 08/2015
1	Airway Obstruction (Choking) 12/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023
1	Cystic Fibrosis (Mucoviscidosis) 12/2023
1	Hypersensitivity (Allergy) 09/2022
1	Food Hypersensitivity (Food Allergy) 09/2022
1	Immediate Hypersensitivity 09/2022
1	Peanut Hypersensitivity (Peanut Allergy) 09/2022
1	Nasal Polyps (Nasal Polyp) 01/2022
1	Eosinophilia 01/2021

Drug/Important Bio-Agent (IBA)

3	prostaglandin D2 receptorIBA 01/2022 - 09/2018
3	Prostaglandin D2IBA 01/2021 - 09/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020 - 12/2014
3	Tiotropium Bromide (Spiriva)FDA Link 01/2018 - 01/2015
3	Muscarinic AntagonistsIBA 01/2018 - 08/2015
3	Bronchodilator Agents (Bronchodilators)IBA 01/2017 - 09/2014
3	indacaterolIBA 01/2017 - 12/2014
2	SmokeIBA 12/2023 - 01/2023
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2023 - 01/2023
2	AllergensIBA 02/2023 - 09/2022
2	fevipiprantIBA 01/2022 - 01/2021
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2015
1	CytokinesIBA 02/2023
1	tezepelumabIBA 02/2023
1	Thymic Stromal LymphopoietinIBA 02/2023
1	Monoclonal AntibodiesIBA 02/2023
1	Immunoglobulin FragmentsIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ligelizumabIBA 09/2022
1	Immunoglobulin E (IgE)IBA 09/2022
1	talizumab (TNX901)IBA 09/2022
1	anti-IgE antibodiesIBA 09/2022
1	IgE Receptors (Fc epsilon RI)IBA 09/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	LipidsIBA 09/2018
1	GoldIBA 08/2015
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2015
1	Salmeterol Xinafoate (Serevent)FDA Link 12/2014
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2014

Therapy/Procedure

4	Therapeutics 02/2023 - 04/2014
4	Nebulizers and Vaporizers (Inhaler) 03/2020 - 01/2017
1	Biological Therapy 02/2023
1	Injections 03/2020
1	Respiratory Therapy (Therapy, Respiratory) 06/2018
1	Self Administration (Administration, Self) 06/2018
1	Dry Powder Inhalers 06/2018